相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase I Trial of 2-Methoxyestradiol NanoCrystal Dispersion in Advanced Solid Malignancies
Amye J. Tevaarwerk et al.
CLINICAL CANCER RESEARCH (2009)
Pharmacologic Inhibition of the TGF-β Type I Receptor Kinase Has Anabolic and Anti-Catabolic Effects on Bone
Khalid S. Mohammad et al.
PLOS ONE (2009)
Risks and benefits of bisphosphonates
R. E. Coleman
BRITISH JOURNAL OF CANCER (2008)
NVP-AUY922: A novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis
Suzanne A. Eccles et al.
CANCER RESEARCH (2008)
Emerging robe of bisphosphonates in the clinic - Antitumor activity and prevention of metastasis to bone
Allan Lipton
CANCER TREATMENT REVIEWS (2008)
Hypoxia-selective targeting by the bioreductive prodrug AQ4N in patients with solid tumors: Results of a phase I study
Mark R. Albertella et al.
CLINICAL CANCER RESEARCH (2008)
VEGF-C, a lymphatic growth factor, is a RANKL target gene in osteoclasts that enhances osteoclastic bone resorption through an autocrine mechanism
Qian Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF
H. J. Knowles et al.
JOURNAL OF PATHOLOGY (2008)
Significant antitumor activity in vivo following treatment with the microtubule agent ENMD-1198
Theresa M. LaVallee et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia
Aline Bozec et al.
NATURE (2008)
The effect of 2-methoxyestradiol, a HIF-1α inhibitor, in global cerebral ischemia in rats
Dachun Zhou et al.
NEUROLOGICAL RESEARCH (2008)
Molecular Origins of Cancer Molecular Basis of Metastasis
Anne C. Chiang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Bevacizumab inhibits breast cancer-induced osteolysis, surrounding soft tissue metastasis, and angiogenesis in rats as visualized by VCT and MRI
Tobias Baeuerle et al.
NEOPLASIA (2008)
2-methoxyestradiol suppresses osteolytic breast cancer tumor progression in vivo
Muzaffer Cicek et al.
CANCER RESEARCH (2007)
Oxygen tension is an important mediator of the transformation of osteoblasts to osteocytes
Makoto Hirao et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2007)
Expression of collagenase-1 (MMP-1) promotes melanoma growth through the generation of active transforming growth factor-β
Joji Iida et al.
MELANOMA RESEARCH (2007)
Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer
Toru Hiraga et al.
CANCER RESEARCH (2007)
Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic
Mingfang Ao et al.
CANCER RESEARCH (2007)
Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis
Delphine Javelaud et al.
CANCER RESEARCH (2007)
Enhanced bone regeneration associated with decreased apoptosis in mice with partial HIF-1α deficiency
David E. Komatsu et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
The human Cyr61 gene is a transcriptional target of transforming growth factor beta in cancer cells
Laurent Bartholin et al.
CANCER LETTERS (2007)
Mechanisms underlying TGF-β1-induced expression of VEGF and Flk-1 in mouse macrophages and their implications for angiogenesis
Seong-Hyun Jeon et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Hypoxia-inducible factor-1α is a key regulator of metastasis in a transgenic model of cancer initiation and progression
Debbie Liao et al.
CANCER RESEARCH (2007)
Ki26894, a novel transforming growth factor-beta type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line
Shogo Ehata et al.
CANCER SCIENCE (2007)
The hypoxia-inducible factor a pathway couples angiogenesis to osteogenesis during skeletal development
Ying Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis
Jianhua Wang et al.
CANCER AND METASTASIS REVIEWS (2006)
Inhibition of growth and metastasis of mouse mammary carcinoma by selective inhibitor of transforming growth factor-β type I receptor kinase in vivo
Rongrong Ge et al.
CLINICAL CANCER RESEARCH (2006)
Inhibition of pulmonary and skeletal metastasis by a transforming growth factor-β type I receptor kinase inhibitor
Abhik Bandyopadhyay et al.
CANCER RESEARCH (2006)
The tumor suppressor Smad4 is required for transforming growth factor β-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells
M Deckers et al.
CANCER RESEARCH (2006)
Bone loss and fracture risk associated with cancer therapy
Theresa A. Guise
ONCOLOGIST (2006)
Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-κB ligand pathway
MS Bendre et al.
CANCER RESEARCH (2005)
Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway
YB Kang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1α
RJ Phillips et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Mechanisms of disease: Mechanisms of bone metastasis
GD Roodman
NEW ENGLAND JOURNAL OF MEDICINE (2004)
2-methoxyestradiol inhibits hypoxia-inducible factor lot, tumor growth, and angiogenesis and augments paclitaxel efficacy in head and neck squamous cell carcinoma
JL Ricker et al.
CLINICAL CANCER RESEARCH (2004)
Transforming growth factor β receptor I kinase inhibitor down-regulates cytokine secretion and multiple myeloma cell growth in the bone marrow microenvironment
T Hayashi et al.
CLINICAL CANCER RESEARCH (2004)
SD-208, a novel transforming growth factor β receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo
M Uhl et al.
CANCER RESEARCH (2004)
Exploiting tumour hypoxia in cancer treatment
JM Brown et al.
NATURE REVIEWS CANCER (2004)
A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases
JJ Yin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer
H Tamamura et al.
FEBS LETTERS (2003)
Hypoxia is a major stimulator of osteoclast formation and bone resorption
TR Arnett et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2003)
A multigenic program mediating breast cancer metastasis to bone
YB Kang et al.
CANCER CELL (2003)
2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF
NJ Mabjeesh et al.
CANCER CELL (2003)
Dose-response effects of 2-methoxyestradiol on estrogen target tissues in the ovariectomized rat
JD Sibonga et al.
ENDOCRINOLOGY (2003)
Mechanism of action of 2-methoxyestradiol: new developments
SL Mooberry
DRUG RESISTANCE UPDATES (2003)
HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors
HLK Janssen et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Metastasis to bone: Causes, consequences and therapeutic opportunities
GR Mundy
NATURE REVIEWS CANCER (2002)
Transforming growth factor-β stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways
SM Käkönen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effects
YA Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Hypoxia - A key regulatory factor in tumour growth
AL Harris
NATURE REVIEWS CANCER (2002)
Synergistic cooperation between hypoxia and transforming growth factor-β pathways on human vascular endothelial growth factor gene expression
T Sánchez-Elsner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
